Patients with acromegaly might not be at higher risk for dopamine agonist- induced impulse control disorders than those with prolactinomas
Yazar
ÇELİK, Emir
DURCAN, Emre
Sahin, Humeyra Rekali
POYRAZ, BURÇ ÇAĞRI
KADIOĞLU, Pınar
ÖZKAYA, Hande Mefkure
Sahin, Serdar
Korkmaz, Ozge Polat
Üst veri
Tüm öğe kaydını gösterÖzet
Objective: To evaluate the prevalence of impulse control disorders (ICD) and psychiatric symptoms in patients with acromegaly receiving dopamine agonists (DA) in comparison with those with prolactinoma, nonfunctioning pituitary adenomas (NFA), and healthy controls (HC).
Koleksiyonlar
- Makale [92796]